Targeted Mass Spectrometry Assays for Specific Quantification of Urinary proPSA Isoforms | Journal of Proteome Research
![2]proPSA is an early marker for prostate cancer aggressiveness | Prostate Cancer and Prostatic Diseases 2]proPSA is an early marker for prostate cancer aggressiveness | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fpcan.2013.50/MediaObjects/41391_2014_Article_BFpcan201350_Fig2_HTML.jpg)
2]proPSA is an early marker for prostate cancer aggressiveness | Prostate Cancer and Prostatic Diseases
![Area under the receiver operating curve (AUC) for percentage of isoform... | Download Scientific Diagram Area under the receiver operating curve (AUC) for percentage of isoform... | Download Scientific Diagram](https://www.researchgate.net/publication/364476437/figure/fig2/AS:11431281091094764@1666307424090/Area-under-the-receiver-operating-curve-AUC-for-percentage-of-isoform-2-proPSA.jpg)
Area under the receiver operating curve (AUC) for percentage of isoform... | Download Scientific Diagram
![−2]proPSA versus ultrasensitive PSA fluctuations over time in the first year from radical prostatectomy, in an high-risk prostate cancer population: A first report | BMC Urology | Full Text −2]proPSA versus ultrasensitive PSA fluctuations over time in the first year from radical prostatectomy, in an high-risk prostate cancer population: A first report | BMC Urology | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12894-016-0131-0/MediaObjects/12894_2016_131_Fig1_HTML.gif)
−2]proPSA versus ultrasensitive PSA fluctuations over time in the first year from radical prostatectomy, in an high-risk prostate cancer population: A first report | BMC Urology | Full Text
![The prostate health index and the percentage of [-2]proPSA maintain their diagnostic performance when calculated with total and free PSA from different manufacturers The prostate health index and the percentage of [-2]proPSA maintain their diagnostic performance when calculated with total and free PSA from different manufacturers](https://www.degruyter.com/document/doi/10.1515/cclm-2021-0554/asset/graphic/j_cclm-2021-0554_fig_001.jpg)
The prostate health index and the percentage of [-2]proPSA maintain their diagnostic performance when calculated with total and free PSA from different manufacturers
![2proPSA and Prostate Health Index Usefulness for the Diagnosis of Prostate Cancer for PSA Range between 3 and 10 ng/ml 2proPSA and Prostate Health Index Usefulness for the Diagnosis of Prostate Cancer for PSA Range between 3 and 10 ng/ml](https://clinmedjournals.org/articles/iauc/iauc-4-041-002.gif)
2proPSA and Prostate Health Index Usefulness for the Diagnosis of Prostate Cancer for PSA Range between 3 and 10 ng/ml
![The performance of [-2]proPSA and prostate health index tumor markers in prostate cancer diagnosis | Semantic Scholar The performance of [-2]proPSA and prostate health index tumor markers in prostate cancer diagnosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ecdd5f624a5c9ed7cb3cbb34a95a53b6aefc001c/3-Table2-1.png)
The performance of [-2]proPSA and prostate health index tumor markers in prostate cancer diagnosis | Semantic Scholar
![The performance of [-2]proPSA and prostate health index tumor markers in prostate cancer diagnosis | Semantic Scholar The performance of [-2]proPSA and prostate health index tumor markers in prostate cancer diagnosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ecdd5f624a5c9ed7cb3cbb34a95a53b6aefc001c/4-Table4-1.png)
The performance of [-2]proPSA and prostate health index tumor markers in prostate cancer diagnosis | Semantic Scholar
![2]proPSA e Prostate Health Index (phi): che cosa sono? quando sono utili? - Dr. Francesco Varvello, urologo e andrologo 2]proPSA e Prostate Health Index (phi): che cosa sono? quando sono utili? - Dr. Francesco Varvello, urologo e andrologo](https://image.jimcdn.com/app/cms/image/transf/none/path/s21d176b569682d9d/image/icb5469c22bc7d9a6/version/1605475842/image.png)